Translation to Healthcare
By empowering breakthrough solutions in molecular life science and AI, SciLifeLab enable the rapid integration of precision medicine innovations into Sweden’s healthcare system.
As health is individual, patients can benefit greatly from personalized treatments, tailored for their specific molecular disposition. Precision Medicine, relies on technology development and requires close collaboration between scientists and healthcare professionals.
SciLifeLab aims to bring cutting-edge technologies, first-class expertise and data infrastructure to build the foundation of tomorrow’s Precision Medicine.
Skip to
About
Steering board
Operations
Resources
News & examples
Contact
Other initiatives
About
Breakthrough technologies in molecular life science to power precision medicine and tomorrow’s healthcare
Our vision is that by 2035, Sweden will be a world leader in introducing groundbreaking biotechnologies and AI in medicine to ensure patient-centred, transformative health care. To achieve this, we are establishing a unique cluster of excellence that enables the continuous and fast translation of cutting-edge molecular profiling and imaging with AI-powered data analysis to Sweden’s university hospitals. The cluster will thus enable precision medicine of the future, change healthcare and promote the growth of new companies.
Core implementation concept of the excellence cluster to create a set of joint precision medicine units where SciLifeLab technology and data experts and clinicians work side by side.
Key objectives
- Establish complementary molecular medicine units at the seven universities and university hospitals, jointly operated with SciLifeLab.
- Develop joint secure data environment to integrate clinical and molecular data at scale.
- Develop AI-driven data analysis and provide decision support tools to use molecular insights in clinical practice.
- Scale technology innovation through co-creation with industry, creation of spin-offs and commercial partnerships.
- Create new technology-based precision medicine infrastructure for clinical trials to improve patient stratification and provide new explorative endpoints.
- Provide an environment to attract additional investments.
Steering Board
SciLifeLab
- Jan Ellenberg, Director SciLifeLab
- Mia Phillipson, Co-director SciLifeLab
- Annika Jenmalm Jensen, Infrastructure director SciLifeLab
Universities
- Clara Hellner, Research and innovation director Karolinska Institutet
- Carl Johan Sundberg, Dean KI Nord Karolinska Institutet
- Amelie Eriksson Karlström, Head of the School CBH, KTH Royal Institute of Technology
- Lena Mäler, Dean faculty of natural sciences Stockholm University
- Eva Tiensuu Janson, Vice President for Research Uppsala University
- Jan Holgersson, Vice dean Infrastructure at the Sahlgrenska academy Gothenburg University and Chalmers
- Olle Melander, Senior consultant, internal medicine at Lund University Lund University
- Katrine Riklund, Deputy Vice-Chancellor Umeå University
- Pending, Örebro University
- Martin Hallbeck, Linköping University
University hospitals
- Christophe Pedroletti, Hospital director Karolinska University hospital, Stockholm
- Mathias Axelsson, Managing Director Medical Diagnostics Karolinska University hospital, Stockholm
- Marianne van Rooijen, Hospital director, University hospital, Uppsala
- Lars Palmqvist, Director Department of Laboratory Medicine Sahlgrenska Universtiy hospital, Gothenburg
- Stefan Jovinge, Research Director Skåne University Hospital
- Tobias Strid, Head of Operations Precision Medicine Laboratory, Linköping University Hospital
- Pia Näsvall, Director of Health and Medical Care, Västerbotten Region
- Pending, Örebro University Hospital
Other organisations
- Richard Rosenqvist Brandell, Director GMS
- Boubou Hallberg, Hospital director, head of SUHA, Swedish University Hospital Alliance
- Niklas Bergh, Senior Medical Director, Translational Sciences & Clinical Development, AstraZeneca
- Olle Melander, University hospital Precision medicine network
Operations
Working groups are assembled to focus on:
- Data and AI infrastructure
- Technology infrastructure
- Innovation and business models
The groups are working on an implementation plan. If you have contibutions or comments, please reach out to the working group leads. Work on ELSI, social sciences and communications related to the project are involved in all working groups.
Data &
AI infrastructure
Working group contact Päivi Östling
Technology infrastructure
Working group contact: Valtteri Wirta
Innovation & industry business models
Working group contact: Per Lek
News & examples
News article – When symptoms are vague, proteins can point the way
Contact
Josefin Lundgren Gawell, Coordinator
Other initiatives
A large number of initiatives and projects are working to strengthens Sweden’s journey in translating technological breakthroughs to clinical practice. A few of those are examplified below.
TEF-Health Sweden
The European Commission has co-funded an initiative to set up Testing and Experimentation facilities (TEFs) for Artificial intelligence (AI) and robotics and Healthcare is one of the targeted sectors in addition to agri-food, manufacturing and smart cities & communities. TEF Health aims to provide expertise and assistance to small and medium sized enterprises (SME) and innovators, promoting the transfer of research innovations to healthcare applications.
IXBI
Integrated X-ray and biomedical imaging for the future of pathology, a Swedish Research Council excellence cluster application with the aim to achieve end-to-end pipeline for biopsies by uniting Sweden’s strengths in clinical imaging; X-ray imaging and tomography; and AI-driven multimodal analysis.